Skip to content

Clinical trials

Phase 3 Behcet Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Behcet Syndrome Phase: Phase 3 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20121
20142
20151
20171
20181
20211
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Assistance Publique - Hôpitaux de Paris2
Ganzhou Hemay Pharmaceutical Co., Ltd1
Janssen Korea, Ltd., Korea1
Marmara University1
Novartis Pharmaceuticals1
Peking Union Medical College Hospital1
Tanabe Pharma Corporation1
University Hospital Tuebingen1
XOMA (US) LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Behcet Syndrome13
Uveitis3
Oral Ulcer2
Panuveitis2
Uveitis, Posterior2
Arthritis, Juvenile1
Postthrombotic Syndrome1
Retinal Vasculitis1
Uveitis, Intermediate1
Vasculitis1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.